Cargando…
Redirecting cell-type specific cytokine responses with engineered interleukin-4 superkines
Cytokines dimerize their receptors, with binding of the “second chain” triggering signaling. In the interleukin (IL)-4/13 system, different cell types express varying levels of alternative second receptor chains (γc or IL-13Rα1), forming functionally distinct Type-I or Type-II complexes. We manipula...
Autores principales: | Junttila, Ilkka S., Creusot, Remi J., Moraga, Ignacio, Bates, Darren L., Wong, Michael T., Alonso, Michael N., Suhoski, Megan M., Lupardus, Patrick, Meier-Schellersheim, Martin, Engleman, Edgar G., Utz, Paul J., Fathman, C. Garrison, Paul, William E., Garcia, K. Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508151/ https://www.ncbi.nlm.nih.gov/pubmed/23103943 http://dx.doi.org/10.1038/nchembio.1096 |
Ejemplares similares
-
Exploiting a natural conformational switch to engineer an Interleukin-2 superkine
por: Levin, Aron M., et al.
Publicado: (2012) -
Interleukin-2 superkines by computational design
por: Ren, Junming, et al.
Publicado: (2022) -
Fine-tuned long-acting interleukin-2 superkine potentiates durable immune responses in mice and non-human primate
por: Merchant, Rosemina, et al.
Publicado: (2022) -
Concise Review: Cell‐Based Therapies and Other Non‐Traditional Approaches for Type 1 Diabetes
por: Creusot, Remi J., et al.
Publicado: (2016) -
It’s Time to Bring Dendritic Cell Therapy to Type 1 Diabetes
por: Creusot, Rémi J., et al.
Publicado: (2014)